Next Article in Journal
Acute Otomastoiditis in Children: An Observational Study on the Role of Mastoid Morphology in the Development of Intracranial Complications
Previous Article in Journal
Bidirectional Interplay Between Traumatic Brain Injury and Cardiovascular Dysfunction in Athletes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Enhancing Safety in Refractive Surgery: A Pilot Evaluation of In Vivo Confocal Microscopy

by
Dominika Janiszewska-Bil
1,2,3,*,
Magdalena Kijonka
4,
Joanna Kokot-Lesiuk
4,
Victor Derhartunian
5,
Anita Lyssek-Boroń
1,3,
Dariusz Dobrowolski
1,4,
Edward Wylęgała
4,
Beniamin Oskar Grabarek
2 and
Katarzyna Krysik
1,3
1
Department of Ophthalmology, St. Barbara Hospital, Trauma Centre, 41-200 Sosnowiec, Poland
2
Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, Poland
3
Department of Ophthalmology, Faculty of Medicine, Academy of Silesia, 40-555 Katowice, Poland
4
Chair and Ophthalmology Clinic Railway Hospital Katowice, Medical University of Silesia, 40-760 Katowice, Poland
5
EyeLaser Clinic, Opernring 1, 1010 Vienna, Austria
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(21), 7714; https://doi.org/10.3390/jcm14217714
Submission received: 27 September 2025 / Revised: 22 October 2025 / Accepted: 27 October 2025 / Published: 30 October 2025

Abstract

Background: In vivo confocal microscopy (IVCM) provides high-resolution corneal imaging that may enhance preoperative and postoperative assessment in refractive surgery. This pilot study aimed to evaluate the diagnostic utility of IVCM in identifying subclinical corneal abnormalities that could influence surgical qualification and outcomes. Methods: A total of 7 patients (3 males, 4 females; mean age 48.8 ± 14.5 years) undergoing qualification or follow-up for refractive surgery were prospectively examined between May 2021 and March 2025. Each participant underwent a comprehensive ophthalmic evaluation, including slit-lamp biomicroscopy, corneal topography, anterior segment optical coherence tomography (AS-OCT), and IVCM using the Heidelberg Retina Tomograph II with Rostock Cornea Module. Patients with prior ocular surgery, active infection, or systemic corneal disease were excluded. Results: IVCM revealed subtle epithelial, stromal, and endothelial abnormalities undetectable by conventional methods. Findings such as Thygeson’s keratitis, pre-Descemet’s dystrophy, and subclinical herpes simplex keratitis led to modifications of surgical plans or disqualification in selected cases. The technique also aided postoperative evaluation of epithelial–stromal interface disorders. Conclusions: IVCM proved to be a valuable adjunct in detecting subclinical corneal pathology, refining patient selection, and improving safety in refractive surgery. Larger multicenter studies are warranted to validate its clinical role and define standardized indications for preoperative screening.

1. Introduction

Refractive surgery has become a widely accepted method for correcting visual impairments such as myopia, hyperopia, and astigmatism [1]. Procedures such as Femtosecond Laser-Assisted In Situ Keratomileusis (Femto-LASIK) and Refractive Lenticule Extraction—Small Incision Lenticule Extraction (ReLEx SMILE) offer patients an effective alternative to spectacles and contact lenses, significantly improving their quality of life [2,3,4]. These advanced surgical techniques have revolutionized corneal refractive procedures by enhancing cutting precision, improving biomechanical predictability, accelerating visual recovery, and reducing the incidence of postoperative complications such as dry eye and ectasia [5]. However, the success and safety of these procedures largely depend on a thorough preoperative evaluation of the cornea [6,7,8].
Corneal pathologies—including scarring, dystrophies, metabolic changes, and inflammatory conditions—can adversely affect surgical outcomes and increase the risk of postoperative complications [9,10]. Identifying these abnormalities before surgery is crucial to ensuring optimal results and preventing vision-threatening sequelae [11]. Although slit-lamp biomicroscopy remains a fundamental tool for assessing corneal integrity, it often lacks the resolution required to detect subtle or early-stage abnormalities [12]. Confocal microscopy has emerged as an advanced diagnostic modality that allows high-resolution, in vivo imaging of the corneal microstructure [13,14]. This non-invasive technique provides detailed visualization of the corneal epithelium, stroma, and endothelium, enabling early detection of subclinical pathologies that could compromise surgical outcomes [15].
Confocal microscopy is particularly valuable in patients with a history of ocular trauma, long-term contact lens use, unexplained visual disturbances, or suspected corneal dystrophies [15]. By revealing microscopic abnormalities such as corneal nerve alterations, inflammatory cell infiltration, or subtle stromal irregularities, this technology refines patient selection criteria, informs surgical planning, and helps minimize the risk of complications such as post-LASIK ectasia or suboptimal refractive results [16,17,18,19].
The present study aims to evaluate the role of confocal microscopy in the preoperative and postoperative assessment of patients undergoing refractive surgery. By analyzing corneal abnormalities in a cohort of surgical candidates, we sought to identify potential risk factors that could influence surgical planning, patient selection, and postoperative outcomes. Understanding the microscopic features of corneal pathology may enhance diagnostic accuracy and refine treatment strategies, ultimately contributing to safer and more effective refractive procedures. Furthermore, integrating confocal microscopy into routine preoperative screening protocols may optimize patient outcomes, improve long-term visual stability, and advance the field of refractive surgery.
It should be noted that in vivo confocal microscopy (IVCM) is a contact-based imaging technique and, although generally safe, carries a minimal risk of corneal epithelial microerosions or, in rare cases, secondary infection if aseptic conditions are not strictly maintained. In this study, all examinations were performed in a controlled hospital environment by experienced clinicians using sterile techniques, and no adverse events were observed.

2. Materials and Methods

2.1. Study Design

This prospective observational case series included seven consecutive patients who underwent IVCM during their refractive surgery consultation or follow-up between May 2021 and March 2025. All examinations were conducted prospectively, meaning that IVCM imaging was performed at the time of each patient’s clinical visit rather than retrospectively from archived data.
The cohort comprised five preoperative candidates and two postoperative patients referred for IVCM assessment due to new or unexplained visual symptoms following previous refractive surgery or in preparation for planned enhancement procedures. This design allowed evaluation of the diagnostic value of IVCM in both preoperative screening and postoperative assessment contexts.
Each patient underwent a comprehensive ophthalmic assessment, including a detailed medical history obtained through interviews and review of clinical records. Clinical examinations were performed using slit-lamp biomicroscopy, and findings were documented photographically. Following standard evaluation, IVCM was conducted to further assess corneal microstructure.
Although the primary focus was preoperative assessment, one postoperative case (Patient 6) was included to demonstrate the utility of IVCM in detecting delayed epithelial and stromal interface complications after laser refractive surgery. Inclusion of this case highlights the broader applicability of IVCM, not only for preoperative screening but also for diagnosing postoperative structural abnormalities that may affect visual stability and patient satisfaction.
All participants provided written informed consent prior to enrollment after receiving a detailed explanation of the study’s objectives, procedures, and potential risks.
During the recruitment period (May 2021–March 2025), 28 consecutive patients were offered IVCM as part of their refractive surgery qualification or postoperative evaluation. Of these, seven patients (25%) provided written informed consent and completed the examination. The remaining 21 declined participation, citing the contact-based nature of the procedure, time constraints, or anticipated discomfort. This acceptance rate reflects both the limited availability of IVCM and the selectivity of patients willing to undergo detailed microstructural assessment, introducing a potential selection bias acknowledged in the interpretation of results.
Given the specialized nature of this study, the sample size was intentionally limited. In clinical practice, patients with significant corneal abnormalities are usually excluded from refractive surgery at earlier qualification stages. This study therefore focused on a subgroup of motivated patients who remained eligible for refractive procedures despite subtle or borderline findings. Moreover, as IVCM is not routinely performed during standard preoperative evaluations, its use was limited to specialized hospital-based settings requiring patient cooperation for a time-consuming, mildly invasive examination. These factors collectively contributed to the small study population, which nonetheless yielded valuable clinical insights.

2.2. Patient Data

This prospective study included seven patients evaluated for refractive surgery at our ophthalmology departments. All participants provided written informed consent before enrollment. Inclusion criteria encompassed individuals with myopia, hyperopia, or astigmatism who were candidates for laser vision correction procedures, including Femto-LASIK, ReLEx SMILE, or phakic intraocular lens (ICL) implantation.
Patients with a history of ocular surgery, active ocular infection, or systemic conditions affecting the cornea were excluded. Each participant underwent a comprehensive ophthalmic evaluation including best-corrected visual acuity (BCVA), manifest and cycloplegic refraction, slit-lamp biomicroscopy, corneal topography (Pentacam, Oculus Optikgeräte GmbH, Wetzlar, Germany), and pachymetry. Additional diagnostic tests included anterior segment optical coherence tomography (AS-OCT, Triton, Topcon, Warsaw, Poland) to assess corneal morphology, epithelial thickness mapping, and endothelial cell density measurement using specular microscopy.

2.3. IVCM (HRT2-RCM)

IVCM was performed using the Heidelberg Retina Tomograph II (HRT II) equipped with the Rostock Cornea Module (Heidelberg Engineering GmbH, Heidelberg, Germany). To ensure optimal image quality and prevent air bubble formation, a generous amount of Comfort Gel ophthalmic ointment (Bausch & Lomb GmbH, Berlin, Germany) was applied to the front surface of the microscope lens. A Tomo-Cap (Heidelberg Engineering GmbH) was securely mounted on the lens holder to maintain stable and uniform contact with the corneal surface.
Both the central and peripheral regions of the cornea were systematically scanned layer by layer. The HRT2-RCM utilizes a 360° water-immersion objective lens (Olympus Europa GmbH, Hamburg, Germany) and a 670 nm diode laser light source. The system captures 384 × 384-pixel images over a 400 × 400 µm field of view. Each eye was examined twice during the patient’s initial visit to ensure the consistency and accuracy of imaging results.
In addition to qualitative evaluation, a semi-quantitative assessment was performed using established parameters described in the literature. Corneal nerve fiber density (CNFD) and corneal nerve fiber length (CNFL) were estimated based on standardized confocal microscopy reference images, while keratocyte reflectivity was graded on a 0–3 scale (0 = absent, 1 = mild, 2 = moderate, 3 = marked) according to Hovakimyan et al. [20]. Hyper-reflective deposits, interface disruptions, and nerve irregularities were analyzed in at least five representative frames per corneal layer. Although the small sample size precluded statistical testing, these standardized grading approaches facilitated intra-case comparisons and ensured reproducibility of descriptive findings.

3. Results

This study included seven patients (four females, three males) who underwent comprehensive ophthalmic evaluation and in vivo confocal microscopy (IVCM) either prior to or following refractive surgery qualification. Confocal microscopy significantly influenced clinical decision-making by revealing subclinical abnormalities or confirming diagnoses that affected surgical eligibility or the choice of procedure.
Patient 1—A 52-year-old female with a history of long-term contact lens use presented with punctate epithelial opacities. IVCM revealed subepithelial hyper-reflective deposits and irregularities in the subnasal nerve plexus, findings consistent with Thygeson’s superficial punctate keratitis (TSPK). These abnormalities, together with her clinical symptoms, led to disqualification from refractive surgery due to the increased risk of postoperative complications and recurrence of epithelial lesions (Figure 1).
Patient 2—A 30-year-old female with high myopia and astigmatism exhibited a Hudson–Stähli line during slit-lamp examination—an iron deposition line typically regarded as benign. Although IVCM did not reveal any stromal or endothelial abnormalities, the patient was disqualified from surgery due to suspected corneal biomechanical instability, which posed an elevated risk of postoperative ectasia (Figure 2).
Patient 3—A 49-year-old female with a remote history of corneal foreign body removal underwent IVCM, which confirmed a sharply demarcated stromal scar without evidence of active inflammation or keratocyte activation. The absence of subclinical pathology indicated a low surgical risk, and the patient was qualified for laser vision correction (Figure 3).
Patient 4—A 29-year-old male scheduled for ReLEx SMILE had a faint superficial corneal scar identified during slit-lamp examination. IVCM confirmed that the lesion was confined to the epithelial layer, with no involvement of the stroma or signs of inflammation. The surgery was successfully performed without complications (Figure 4).
Patient 5—A 54-year-old female with high myopia, reduced corneal thickness, and a large pupil was diagnosed with pre-Descemet’s corneal dystrophy based on IVCM findings. Hyper-reflective stromal deposits were observed in the absence of endotheliitis. Due to insufficient stromal thickness for laser ablation, phakic intraocular lens (ICL) implantation was proposed. The patient was counseled regarding possible night vision disturbances associated with her large scotopic pupil (Figure 5).
Patient 6—A 56-year-old male with a history of Femto-LASIK three years earlier presented with fluctuating visual acuity. IVCM revealed epithelial–stromal interface irregularities, including basement membrane disruption and epithelial cell disarray, indicative of secondary Cogan’s dystrophy. Based on these findings, phototherapeutic keratectomy (PTK) was performed instead of flap-lift enhancement, resulting in improved uncorrected visual acuity (Figure 6).
Patient 7—A 58-year-old asymptomatic male presented with a subtle subepithelial lesion. IVCM demonstrated early features of subclinical herpes simplex keratitis (HSK), including activated keratocytes and increased stromal reflectivity. Although asymptomatic, the patient received prophylactic oral acyclovir before surgery to reduce the risk of postoperative viral reactivation (Figure 7).
A summary of patient demographics, clinical histories, IVCM findings, and surgical outcomes is presented in Table 1.
For clarity, hyper-reflective deposits were defined as discrete, bright stromal or subepithelial foci exhibiting > 30% higher reflectivity than the surrounding keratocytes within the same frame. Nerve irregularities referred to disorganization or fragmentation of the sub-basal nerve plexus, while interface disruptions denoted discontinuities or folds at the epithelial–stromal boundary.
The mean corneal nerve fiber length (CNFL) across the analyzed eyes was 16.2 ± 3.1 mm/mm2, and the average keratocyte density in unaffected stromal regions was 978 ± 110 cells/mm2, consistent with published normative values. These semi-quantitative findings corroborate the qualitative interpretation of microstructural alterations detected by IVCM.

4. Discussion

IVCM has proven to be a valuable tool for the detailed assessment of corneal microstructure, providing high-resolution imaging of the epithelial, stromal, and endothelial layers [15]. This study demonstrated its clinical utility in both pre- and postoperative evaluations of refractive surgery candidates by identifying subtle corneal abnormalities undetectable through conventional examination methods. Our findings align with previous research, confirming that IVCM can reveal subclinical pathological changes—such as inflammatory infiltrates, nerve plexus alterations, and metabolic deposits—thereby improving surgical planning and risk assessment. Although this was a prospective study, the inclusion of postoperative and subclinical cases reflects real-world clinical practice, in which IVCM was prospectively applied to all referred patients, regardless of whether they were first-time surgical candidates or had undergone prior refractive procedures. This approach highlights the broader diagnostic relevance of IVCM beyond a purely preoperative context.
While this pilot study did not include a direct quantitative comparison between slit-lamp examination alone and slit-lamp assessment combined with IVCM, our observations illustrate how IVCM provided additional diagnostic insights that refined clinical judgment in several cases. The technique revealed microstructural alterations invisible under slit-lamp biomicroscopy, allowing for more confident qualification or disqualification of candidates. Future prospective studies with controlled, comparative designs are warranted to objectively quantify the diagnostic yield and clinical impact of IVCM relative to standard preoperative modalities [17,19].
A representative case is Patient 1, a 52-year-old female with long-term contact lens use, initially suspected of having adenoviral keratitis. IVCM confirmed the diagnosis of Thygeson’s superficial punctate keratitis (TSPK), a rare, noninfectious condition characterized by bilateral, recurrent punctate epithelial opacities without stromal involvement [21,22,23,24]. Prior studies, including those by Kobayashi et al., have described reflective epithelial deposits and subepithelial haze as characteristic IVCM findings in TSPK [17]. These characteristic IVCM features were also observed in our case, confirming the diagnosis and justifying disqualification from refractive surgery. This finding highlights the pivotal role of IVCM in resolving ambiguous or overlapping clinical presentations, particularly when slit-lamp or topographic findings are inconclusive [25].
In Patient 2, a 30-year-old female with high myopia and astigmatism, slit-lamp biomicroscopy revealed a Hudson–Stähli line—an iron deposition within the corneal epithelium typically considered benign [26,27]. IVCM confirmed a normal corneal microstructure, indicating no stromal or endothelial pathology. The patient was disqualified from surgery not due to IVCM findings, which were unremarkable, but because of corneal biomechanical risk factors detected during topography and pachymetry. Thus, IVCM played a confirmatory role, ruling out microstructural pathology rather than directly determining surgical eligibility [28,29].
Patient 3, with a history of prior corneal foreign body removal, demonstrated a well-demarcated stromal scar without signs of active inflammation on IVCM. This finding supported surgical qualification and reinforced earlier evidence that confocal microscopy can distinguish quiescent stromal scarring from subclinical inflammation or keratocyte activation [20].
In Patient 4, a 29-year-old female scheduled for ReLEx SMILE, slit-lamp examination raised concern due to a superficial corneal scar. IVCM confirmed that the lesion was confined to the epithelial layer, with no stromal involvement or inflammatory changes. The surgery was subsequently performed without complications, demonstrating how IVCM can clarify the clinical relevance of corneal scars by differentiating benign surface irregularities from deeper lesions that may compromise refractive outcomes [28,30].
Patient 5, a 54-year-old female with high myopia and reduced corneal thickness, was diagnosed with pre-Descemet’s corneal dystrophy based on IVCM findings, which showed hyper-reflective stromal deposits in the absence of endotheliitis. This confirmation supported the choice of phakic intraocular lens (ICL) implantation, as corneal thickness was insufficient for laser ablation [31]. The patient’s large scotopic pupil required preoperative counseling regarding potential night vision disturbances, although it did not alter the procedural plan [32].
A postoperative case, Patient 6, involved a 56-year-old male who had undergone Femto-LASIK three years earlier and presented with fluctuating visual acuity. IVCM revealed epithelial–stromal interface irregularities, including basement membrane disruption and epithelial disarray, consistent with secondary Cogan’s dystrophy [33]. Based on these findings, PTK was performed instead of flap-lift enhancement, resulting in improved uncorrected visual acuity [34,35].
This case underscores the utility of IVCM in postoperative settings, where it aids in differentiating dystrophic or structural interface abnormalities from inflammatory or infectious causes of visual fluctuation [28].
Finally, Patient 7, an asymptomatic 58-year-old male with a subtle subepithelial lesion, exhibited IVCM findings consistent with subclinical herpes simplex keratitis (HSK), including activated keratocytes and increased stromal reflectivity. Although clinically silent, the patient received prophylactic oral acyclovir prior to surgery to mitigate the risk of postoperative viral reactivation [36].
Because the risk of postoperative corneal ectasia is primarily governed by corneal biomechanical stability, integrating IVCM with quantitative biomechanical assessments—such as Corvis ST dynamic Scheimpflug imaging or the Ocular Response Analyzer—could yield a more comprehensive preoperative risk profile. These instruments were unavailable during the present study, representing a methodological limitation. Future research protocols should combine IVCM-derived microstructural parameters with biomechanical indices such as deformation amplitude, corneal hysteresis, or stiffness parameter at first applanation to enhance predictive modeling and individualized risk stratification for refractive surgery candidates [37,38].
Based on our observations and prior literature, we propose that IVCM should be selectively employed in patients with: (1) a history of long-term contact lens wear or recurrent keratitis; (2) borderline corneal thickness or irregular topography; (3) unexplained visual symptoms incongruent with slit-lamp or topographic findings; or (4) suspected early dystrophic, inflammatory, or viral changes. Incorporating IVCM at these critical decision points may help identify subclinical contraindications and enhance surgical safety. Although IVCM systems require substantial investment and operator expertise, their implementation may be justified in tertiary or referral centers where refractive surgery volume and diagnostic precision directly affect patient safety. In non-tertiary settings, regional collaboration or referral for IVCM imaging could optimize resource utilization while maintaining safety standards.
This study has several limitations. First, the small and heterogeneous cohort (n = 7) limits statistical power and generalizability. Second, although all patients were examined prospectively, inclusion of both preoperative and postoperative cases introduces clinical heterogeneity. Third, no longitudinal follow-up data on postoperative outcomes were collected. Fourth, the study was conducted at a single tertiary center without a control group, and corneal biomechanical testing (Corvis ST/ORA) was unavailable. Finally, the limited acceptance rate for IVCM introduces potential selection bias. These factors collectively constrain the strength of the conclusions and should be addressed in future research.
To validate these preliminary findings, larger multicenter studies with standardized protocols are needed. Future investigations should employ harmonized confocal scoring systems, integrate biomechanical and topographic indices, and include longitudinal follow-up of visual and refractive outcomes. Such studies will help determine the predictive value of IVCM for surgical safety and its potential incorporation into evidence-based preoperative screening algorithms.

5. Conclusions

The findings of this study underscore the diagnostic value of IVCM in both the preoperative and postoperative evaluation of refractive surgery candidates. By enabling detailed visualization of microscopic structural alterations—such as subclinical inflammation, epithelial–stromal interface irregularities, and metabolic or dystrophic changes—IVCM provides critical information often undetectable through standard examination techniques. This enhanced diagnostic precision supports more accurate patient selection, facilitates individualized surgical planning, reduces postoperative risk, and ultimately contributes to improved visual outcomes. Although not intended for routine use in all candidates, IVCM serves as an important adjunct in cases with ambiguous or borderline findings.
This pilot study was limited by its small sample size and lack of quantitative comparison. Future studies involving larger, standardized cohorts are warranted to assess its cost-effectiveness, clinical impact, and potential integration into comprehensive preoperative screening algorithms for refractive surgery.

Author Contributions

Conceptualization, D.J.-B.; methodology, D.J.-B.; formal analysis, D.D. and M.K.; investigation, D.J.-B. and V.D.; resources, E.W. and J.K.-L.; writing—original draft preparation, D.J.-B., A.L.-B. and K.K.; writing—review and editing, D.J.-B. and B.O.G.; visualization, B.O.G.; supervision, K.K.; project administration, B.O.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethical Committee of the Regional Medical Chamber in Krakow (protocol code 68/KBL/OIL/2021, date of approval: 19 March 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Acknowledgments

The authors express their gratitude to Nikola Zmarazły for expert support in the preparation and refinement of the figures.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BCVABest-Corrected Visual Acuity
Femto-LASIKFemtosecond Laser-Assisted In Situ Keratomileusis
HSKHerpes Simplex Keratitis
ICLImplantable Collamer Lens (Phakic Intraocular Lens)
IVCMIn Vivo Confocal Microscopy
OCTOptical Coherence Tomography
ODOculus Dexter (Right Eye)
OSOculus Sinister (Left Eye)
PTKPhototherapeutic Keratectomy
SMILESmall Incision Lenticule Extraction
TSPKThygeson’s Superficial Punctate Keratitis

References

  1. Ang, M.; Gatinel, D.; Reinstein, D.Z.; Mertens, E.; Alió del Barrio, J.L.; Alió, J.L. Refractive Surgery beyond 2020. Eye 2021, 35, 362–382. [Google Scholar] [CrossRef] [PubMed]
  2. Miraftab, M.; Hashemi, H.; Aghamirsalim, M.; Fayyaz, S.; Asgari, S. Matched Comparison of Corneal Higher Order Aberrations Induced by SMILE to Femtosecond Assisted LASIK and to PRK in Correcting Moderate and High Myopia: 3.00 Mm vs. 6.00 Mm. BMC Ophthalmol. 2021, 21, 216. [Google Scholar] [CrossRef]
  3. Shah, R. History and Results; Indications and Contraindications of SMILE Compared with LASIK. Asia-Pac. J. Ophthalmol. 2019, 8, 371. [Google Scholar] [CrossRef]
  4. Breyer, D.R.; Beckers, L.; Hagen, P.; Kaymak, H.; Klabe, K.; Auffarth, G.U.; Kretz, F.T.A. Comparison of Long-Term Results with Small Incision Refractive Lenticule Extraction (ReLEX SMILE) vs. Femto-LASIK. Klin. Monatsblatter Fur Augenheilkd. 2019, 236, 1201–1207. [Google Scholar]
  5. Li, J.; Huang, Y.; Song, Y.; Xu, Y.; Zhang, Y.; Wen, J.; Wang, Z.; Zhang, F. Epithelial remodeling associated with corneal power and corneal higher-order aberrations after ray-tracing guided FS-LASIK for myopia. Photodiagnosis Photodyn. Ther. 2025, 56, 105230. [Google Scholar] [CrossRef] [PubMed]
  6. Pazo, E.E.; Huang, H.; Fan, Q.; Zhang, C.; Yue, Y.; Yang, L.; Xu, L.; Moore, J.E.; He, W. Intense Pulse Light for Treating Post-LASIK Refractory Dry Eye. Photobiomodul. Photomed. Laser Surg. 2021, 39, 155–163. [Google Scholar] [CrossRef] [PubMed]
  7. Yalçınkaya, G.; Yıldız, B.K.; Çakır, İ.; Yıldırım, Y.; Demirok, A. Evaluation of Peripapillary-Macular Microvascularity and Choroidal Vascularity Index after Refractive Surgery. Photodiagnosis Photodyn. Ther. 2022, 37, 102714. [Google Scholar] [CrossRef]
  8. Greenstein, S.A.; Hersh, P.S. Update on corneal crosslinking for keratoconus and corneal ectasia. Curr. Opin. Ophthalmol. 2024, 35, 273–277. [Google Scholar] [CrossRef]
  9. Jain, N.; Murthy, S.; Rathi, V.M.; Das, S.; Jakati, S.; Mishra, D.K.; Vemuganti, G.K.; Ramappa, M. Corneal Pathology. In Ocular Pathology: Basics to Clinico-Pathologic Correlation; Vemuganti, G.K., Murthy, S., Mishra, D.K., Eds.; Springer Nature: Singapore, 2025; pp. 149–187. ISBN 978-981-96-8614-8. [Google Scholar]
  10. Dumitrache, M. Ophthalmological Pathology and Management in Eye Disease: Cornea. In Clinical Ophthalmology: A Guide to Diagnosis and Treatment; Dumitrache, M., Ed.; Springer Nature: Cham, Switzerland, 2024; pp. 139–197. ISBN 978-3-031-68453-1. [Google Scholar]
  11. Ibrahim, R.; Kumar, P.; Aranjani, J.M. Microbial keratitis in the age of resistance: Unlocking the therapeutic potential of phage therapy. Graefe’s Arch Clin. Exp. Ophthalmol. 2025. [Google Scholar] [CrossRef]
  12. Gurnani, B.; Kaur, K.; Lalgudi, V.G.; Kundu, G.; Mimouni, M.; Liu, H.; Jhanji, V.; Prakash, G.; Roy, A.S.; Shetty, R.; et al. Role of Artificial Intelligence, Machine Learning and Deep Learning Models in Corneal Disorders—A Narrative Review. J. Français D’ophtalmol. 2024, 47, 104242. [Google Scholar] [CrossRef]
  13. Chiang, J.C.B.; Roy, M.; Kim, J.; Markoulli, M.; Krishnan, A.V. In-Vivo Corneal Confocal Microscopy: Imaging Analysis, Biological Insights and Future Directions. Commun. Biol. 2023, 6, 652. [Google Scholar] [CrossRef]
  14. Cañadas, P.; Alberquilla García-Velasco, M.; Hernández Verdejo, J.L.; Teus, M.A. Update on Corneal Confocal Microscopy Imaging. Diagnostics 2022, 13, 46. [Google Scholar] [CrossRef]
  15. Martin, R. Cornea and Anterior Eye Assessment with Slit Lamp Biomicroscopy, Specular Microscopy, Confocal Microscopy, and Ultrasound Biomicroscopy. Indian J. Ophthalmol. 2018, 66, 195–201. [Google Scholar] [CrossRef]
  16. Alvani, A.; Hashemi, H.; Pakravan, M.; Mahbod, M.; Seyedian, M.A.; Amanzadeh, K.; Khabazkhoob, M.; Jafarzadehpur, E.; Fotouhi, A. Post-LASIK Ectasia Versus Keratoconus: An In Vivo Confocal Microscopy Study. Cornea 2020, 39, 1006. [Google Scholar] [CrossRef]
  17. Kobayashi, A.; Sugiyama, K. In Vivo Corneal Confocal Microscopic Findings of Palisades of Vogt and Its Underlying Limbal Stroma. Cornea 2005, 24, 435–437. [Google Scholar] [CrossRef]
  18. Chao, C.; Tajbakhsh, Z.; Stapleton, F.; Mobeen, R.; Madigan, M.C.; Jalbert, I.; Briggs, N.; Golebiowski, B. Corneal Epithelial Dendritic Cells, Tear Neuropeptides and Corneal Nerves Continue to Be Affected More than 12 Months after LASIK. Acta Ophthalmol. 2023, 101, e302–e314. [Google Scholar] [CrossRef] [PubMed]
  19. El Zarif, M.; Abdul Jawad, K.; Alió, J.L.; Makdissy, N.; De Miguel, M.P. In Vivo Confocal Microscopy Evaluation of Infiltrated Immune Cells in Corneal Stroma Treated with Cell Therapy in Advanced Keratoconus. J. Ophthalmic Inflamm. Infect. 2024, 14, 5. [Google Scholar] [CrossRef] [PubMed]
  20. Hovakimyan, M.; Falke, K.; Stahnke, T.; Guthoff, R.; Witt, M.; Wree, A.; Stachs, O. Morphological Analysis of Quiescent and Activated Keratocytes: A Review of Ex Vivo and in Vivo Findings. Curr. Eye Res. 2014, 39, 1129–1144. [Google Scholar] [CrossRef] [PubMed]
  21. Moshirfar, M.; Peterson, T.; Ungricht, E.; McCabe, S.; Ronquillo, Y.C.; Brooks, B.; Towne, F.; Hoopes, P. Thygeson Superficial Punctate Keratitis: A Clinical and Immunologic Review. Eye Contact Lens 2022, 48, 232–238. [Google Scholar] [CrossRef]
  22. Thygeson, P. Superficial Punctate Keratitis. JAMA 1950, 144, 1544–1549. [Google Scholar] [CrossRef]
  23. Mandal, N.; Yeung, S.N.; Tadrous, C.; Iovieno, A. Thygeson’s Superficial Punctate Keratitis. Graefe’s Arch. Clin. Exp. Ophthalmol. 2022, 260, 1837–1841. [Google Scholar] [CrossRef]
  24. Wang, L.; Zhang, Y.; Wei, Z.; Cao, K.; Su, G.; Hamrah, P.; Labbe, A.; Liang, Q. Characteristics of Toxic Keratopathy, an In Vivo Confocal Microscopy Study. Trans. Vis. Sci. Technol. 2021, 10, 11. [Google Scholar] [CrossRef] [PubMed]
  25. You, J.Y.; Botelho, P.J. Corneal In Vivo Confocal Microscopy: Clinical Applications. Rhode Isl. Med. J. 2016, 99, 30–33. [Google Scholar]
  26. Naquin, E.R.; Garg, R.; Chen, W.J.; Karmakar, E.; Prasad, A.; Mandadi, S.; Depala, K.; Gopianand, J.S.; Gnana-Prakasam, J.P. Iron: More than Meets the Eye. Nutrients 2025, 17, 2964. [Google Scholar] [CrossRef]
  27. Al Bdour, M.; Alsaadi, A.; Almaazmi, A.; Alryalat, S.A. Clinical Review of Cornea: Part I. In Ophthalmology Board and FRCS Part 2 Exams: Eye Yield Clinical; Alryalat, S.A., Ed.; Springer Nature: Singapore, 2025; pp. 257–277. ISBN 978-981-96-1517-9. [Google Scholar]
  28. Rozitis, E.; Petsoglou, C.; Devasahayam, R.; Hau, S.; Lacorzana, J. Typical Manifestations of the Different Corneal Deposits by In Vivo Confocal Microscopy (IVCM): A Review. Clin. Exp. Ophthalmol. 2025, 53, 834–857. [Google Scholar] [CrossRef]
  29. Recchioni, A.; Barua, A.; Dominguez-Vicent, A. Enhancing Clinical Decision-Making in Complex Corneal Disorders: The Role of In-Vivo Confocal Microscopy. Life 2023, 13, 679. [Google Scholar] [CrossRef] [PubMed]
  30. Hou, C.; Li, J.; Li, J.; Peng, H.; Wang, Q. In Vivo Confocal Microscopy of Sub-Basal Corneal Nerves and Corneal Densitometry after Three Kinds of Refractive Procedures for High Myopia. Int. Ophthalmol. 2023, 43, 925–935. [Google Scholar] [CrossRef] [PubMed]
  31. Naujokaitis, T.; Auffarth, G.U.; Łabuz, G.; Kessler, L.J.; Khoramnia, R. Diagnostic Techniques to Increase the Safety of Phakic Intraocular Lenses. Diagnostics 2023, 13, 2503. [Google Scholar] [CrossRef]
  32. Gómez-Benlloch, A.; Widmer-Pintos, J.; Arnaldos-López, C. Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy, a Rare Corneal Pathology. Clin. Exp. Optom. 2025, 108, 744–745. [Google Scholar] [CrossRef]
  33. Constantin, C. Corneal Dystrophies: Pathophysiological, Genetic, Clinical, and Therapeutic Considerations. Rom. J. Ophthalmol. 2021, 65, 104–108. [Google Scholar] [CrossRef]
  34. Eker, S.; Oflaz, A.B.; Bozkurt, B. Anterior Segment Swept Source Optical Coherence Tomography and In Vivo Confocal Microscopy Findings in a Case with Bleb-Like Epithelial Basal Membrane Dystrophy. Cornea 2023, 42, 1049–1051. [Google Scholar] [CrossRef]
  35. Ivarsen, A.; Fledelius, W.; Hjortdal, J.Ø. Three-Year Changes in Epithelial and Stromal Thickness after PRK or LASIK for High Myopia. Investig. Ophthalmol. Vis. Sci. 2009, 50, 2061–2066. [Google Scholar] [CrossRef] [PubMed]
  36. Chirapapaisan, C.; Muller, R.T.; Sahin, A.; Cruzat, A.; Cavalcanti, B.M.; Jamali, A.; Pavan-Langston, D.; Hamrah, P. Effect of Herpes Simplex Keratitis Scar Location on Bilateral Corneal Nerve Alterations: An in Vivo Confocal Microscopy Study. Br. J. Ophthalmol. 2022, 106, 319–325. [Google Scholar] [CrossRef] [PubMed]
  37. Pniakowska, Z.; Jurowski, P.; Wierzbowska, J. The Role of Corneal Biomechanical Properties Assessment in Laser Vision Correction ? The Introduction: OphthaTherapy. Ther. Ophthalmol. 2022, 9, 183–186. [Google Scholar] [CrossRef]
  38. Liu, C.-F.; Lee, J.-S.; Sun, C.-C.; Lin, K.-K.; Hou, C.-H.; Yeung, L.; Peng, S.-Y. Correlation between Pigmented Arc and Epithelial Thickness (COPE) Study in Orthokeratology-Treated Patients Using OCT Measurements. Eye 2020, 34, 352–359. [Google Scholar] [CrossRef]
Figure 1. (A) Slit-lamp image of the right eye (OD) showing a bright subepithelial lesion without anterior chamber reaction. The red arrow indicates the central subepithelial punctate opacity, while the green arrow highlights an additional peripheral punctate epithelial lesion. (B) IVCM image of the Bowman’s layer and superficial epithelium (red arrow: focal epithelial hyper-reflectivity). (C) IVCM image at the level of the sub-basal nerve plexus showing irregular, fragmented nerve fibers. (D) IVCM image of the anterior stroma showing preserved stromal architecture. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 1. (A) Slit-lamp image of the right eye (OD) showing a bright subepithelial lesion without anterior chamber reaction. The red arrow indicates the central subepithelial punctate opacity, while the green arrow highlights an additional peripheral punctate epithelial lesion. (B) IVCM image of the Bowman’s layer and superficial epithelium (red arrow: focal epithelial hyper-reflectivity). (C) IVCM image at the level of the sub-basal nerve plexus showing irregular, fragmented nerve fibers. (D) IVCM image of the anterior stroma showing preserved stromal architecture. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g001
Figure 2. Multimodal corneal imaging in a patient with suspected corneal pathology. (A) Slit-lamp photograph of the left eye (OS) showing linear pigment deposition (red arrow). (B) IVCM of the superficial epithelium, (C) sub-basal nerve plexus, and (D) endothelium, all showing normal morphology and intact cellular patterns. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 2. Multimodal corneal imaging in a patient with suspected corneal pathology. (A) Slit-lamp photograph of the left eye (OS) showing linear pigment deposition (red arrow). (B) IVCM of the superficial epithelium, (C) sub-basal nerve plexus, and (D) endothelium, all showing normal morphology and intact cellular patterns. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g002
Figure 3. IVCM image of the cornea in a patient with a history of corneal foreign body. (A) IVCM image of the anterior stroma showing a sharply demarcated corneal scar after a foreign body (red arrow); (B) mid-stromal layer demonstrating absence of active inflammation (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 3. IVCM image of the cornea in a patient with a history of corneal foreign body. (A) IVCM image of the anterior stroma showing a sharply demarcated corneal scar after a foreign body (red arrow); (B) mid-stromal layer demonstrating absence of active inflammation (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g003
Figure 4. Corneal imaging in a patient with a superficial corneal scar qualified for ReLEx SMILE (A) Slit-lamp photograph showing a linear corneal scar visible in biomicroscope (red arrow); (B) IVCM of the epithelium and Bowman’s layer confirming absence of deeper stromal involvement. (C) IVCM at the level of the anterior stroma showing normal stromal keratocyte morphology without fibrosis. (D) IVCM of the mid-stroma revealing well-organized stromal collagen fibers with no evidence of scarring deeper in the cornea (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 4. Corneal imaging in a patient with a superficial corneal scar qualified for ReLEx SMILE (A) Slit-lamp photograph showing a linear corneal scar visible in biomicroscope (red arrow); (B) IVCM of the epithelium and Bowman’s layer confirming absence of deeper stromal involvement. (C) IVCM at the level of the anterior stroma showing normal stromal keratocyte morphology without fibrosis. (D) IVCM of the mid-stroma revealing well-organized stromal collagen fibers with no evidence of scarring deeper in the cornea (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g004
Figure 5. IVCM findings in a patient with suspected pre-Descemet’s dystrophy and low corneal thickness. (A) Slit-lamp photograph showing punctate endothelial changes (red arrow). (B,C) IVCM images of the posterior stroma and Descemet’s membrane, showing thickened pre-Descemet’s region characteristic of pre-Descemet’s dystrophy (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 5. IVCM findings in a patient with suspected pre-Descemet’s dystrophy and low corneal thickness. (A) Slit-lamp photograph showing punctate endothelial changes (red arrow). (B,C) IVCM images of the posterior stroma and Descemet’s membrane, showing thickened pre-Descemet’s region characteristic of pre-Descemet’s dystrophy (red arrow). All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g005
Figure 6. Corneal imaging in a postoperative patient with secondary Cogan’s dystrophy following Femto-LASIK (A) Slit-lamp photograph showing spot thickening of the epithelium visible in biomicroscope (red arrow); (B) IVCM image of the epithelial–stromal interface demonstrating epithelial folds and basement membrane irregularities typical of secondary Cogan’s dystrophy; the red arrow indicates a focal area of basement membrane disruption with hyper-reflective epithelial changes. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 6. Corneal imaging in a postoperative patient with secondary Cogan’s dystrophy following Femto-LASIK (A) Slit-lamp photograph showing spot thickening of the epithelium visible in biomicroscope (red arrow); (B) IVCM image of the epithelial–stromal interface demonstrating epithelial folds and basement membrane irregularities typical of secondary Cogan’s dystrophy; the red arrow indicates a focal area of basement membrane disruption with hyper-reflective epithelial changes. All IVCM images were acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g006
Figure 7. IVCM finding in an asymptomatic patient with subclinical HSK. The image shows hyperreflective activated keratocytes and alterations in the sub-basal nerve plexus consistent with subclinical HSK (red arrow). The IVCM image was acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Figure 7. IVCM finding in an asymptomatic patient with subclinical HSK. The image shows hyperreflective activated keratocytes and alterations in the sub-basal nerve plexus consistent with subclinical HSK (red arrow). The IVCM image was acquired using the Heidelberg Retina Tomograph II–Rostock Cornea Module (field of view: 400 × 400 µm; optical magnification ×800; scale bar = 50 µm).
Jcm 14 07714 g007
Table 1. Summary of Patient Characteristics, Confocal Microscopy Findings, and Surgical Outcomes.
Table 1. Summary of Patient Characteristics, Confocal Microscopy Findings, and Surgical Outcomes.
PatientAge/SexClinical HistoryConfocal Microscopy FindingsDiagnosisClinical
Decision/Outcome
152/FLong-term contact lens useSubepithelial opacitiesThygeson’s superficial punctate keratitisDisqualified from surgery
230/FHigh myopia, astigmatismHudson–Stähli line (iron deposition)Benign corneal iron lineDisqualified due to ectasia risk
349/FCorneal foreign body removal (remote)No active inflammationLow ectasia riskQualified for surgery
429/MScheduled for ReLEx SMILESuperficial corneal scar, no stromal/inflammatory changesScar without contraindicationsSurgery completed without complications
554/FHigh myopia, low corneal thickness, large pupilPre-Descemet’s corneal dystrophy, no endotheliitisDystrophyQualified for phakic ICL implantation
656/MPost-Femto-LASIK (3 years), fluctuating visionFeatures of Cogan’s dystrophySecondary Cogan’s dystrophyTreated with PTK (20 µm), UCVA improved
758/MAsymptomatic, subepithelial lesionSubclinical herpes simplex keratitisHerpes simplex (subclinical)Antiviral prophylaxis (acyclovir) before planned surgery
F, female; M, male.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Janiszewska-Bil, D.; Kijonka, M.; Kokot-Lesiuk, J.; Derhartunian, V.; Lyssek-Boroń, A.; Dobrowolski, D.; Wylęgała, E.; Grabarek, B.O.; Krysik, K. Enhancing Safety in Refractive Surgery: A Pilot Evaluation of In Vivo Confocal Microscopy. J. Clin. Med. 2025, 14, 7714. https://doi.org/10.3390/jcm14217714

AMA Style

Janiszewska-Bil D, Kijonka M, Kokot-Lesiuk J, Derhartunian V, Lyssek-Boroń A, Dobrowolski D, Wylęgała E, Grabarek BO, Krysik K. Enhancing Safety in Refractive Surgery: A Pilot Evaluation of In Vivo Confocal Microscopy. Journal of Clinical Medicine. 2025; 14(21):7714. https://doi.org/10.3390/jcm14217714

Chicago/Turabian Style

Janiszewska-Bil, Dominika, Magdalena Kijonka, Joanna Kokot-Lesiuk, Victor Derhartunian, Anita Lyssek-Boroń, Dariusz Dobrowolski, Edward Wylęgała, Beniamin Oskar Grabarek, and Katarzyna Krysik. 2025. "Enhancing Safety in Refractive Surgery: A Pilot Evaluation of In Vivo Confocal Microscopy" Journal of Clinical Medicine 14, no. 21: 7714. https://doi.org/10.3390/jcm14217714

APA Style

Janiszewska-Bil, D., Kijonka, M., Kokot-Lesiuk, J., Derhartunian, V., Lyssek-Boroń, A., Dobrowolski, D., Wylęgała, E., Grabarek, B. O., & Krysik, K. (2025). Enhancing Safety in Refractive Surgery: A Pilot Evaluation of In Vivo Confocal Microscopy. Journal of Clinical Medicine, 14(21), 7714. https://doi.org/10.3390/jcm14217714

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop